Element Genomics.

PositionTRIANGLE BRIEFS: DURHAM

Belgium-based drugmaker UCB acquired Element Genomics. a small biotech spinout from Duke University, for as much as $30 million. UCB had revenue of about $5.5 billion last year and employs...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT